Related Experiment Videos
Tachycardia detection in ICDs by Boston Scientific : Algorithms, pearls, and pitfalls
Norbert Zanker1, Diane Schuster2, James Gilkerson2
1Guidant Europe NV, Boston Scientific, Green Square, Lambroekstraat 5D, 1831, Diegem, Belgium. norbert.zanker@bsci.com.
Aim:
The aim of this study was to summarize how implantable cardioverter defibrillators (ICDs) by Boston Scientific sense, detect, discriminate rhythms, and classify episodes.
Methods:
Modern devices include multiple programming selections, diagnostic features, therapy options, memory functions, and device-related history features. Device operation includes logical steps from sensing, detection, discrimination, therapy delivery to history recording. The program is designed to facilitate the application of the device algorithms to the individual patient's clinical needs. Features and functions described in this article represent a selective excerpt by the authors from Boston Scientific publicly available product resources.
Conclusion:
Programming of ICDs may affect patient outcomes. Patient-adapted and optimized programming requires understanding of device operation and concepts.